Today: 19 July 2026
P&G stock climbs while Wall Street slides — what’s behind PG’s move and what comes next
5 February 2026
2 mins read

P&G stock climbs while Wall Street slides — what’s behind PG’s move and what comes next

New York, February 5, 2026, 15:10 (EST) — Regular session

  • Procter & Gamble shares up about 1.3% in afternoon trading, outperforming a weak tape
  • Investors rotate toward consumer staples as tech and software sell off on AI-spending worries
  • Recent SEC filings disclosed an insider sale and a proposed sale tied to stock options

Procter & Gamble (PG) shares rose about 1.3% on Thursday afternoon to $158.89, up $2.02 on the day. The stock traded between $156.17 and $159.63, with roughly 9.1 million shares changing hands.

The bounce came as U.S. stocks sank on fresh anxiety over Big Tech’s capital spending, or capex, as companies race to build out artificial intelligence. “We’re seeing this volatility about whether this investment will translate, ultimately, into results,” said Tom Hainlin, an investment strategist at U.S. Bank Wealth Management. Reuters

The tech slide has also fed a rotation into value-oriented pockets of the market, including consumer staples and other “old economy” names. “After years of tech-driven market leadership, the balance of power is shifting as investors rotate toward traditional ‘old economy’ sectors,” said Angelo Kourkafas, senior global investment strategist at Edward Jones. Reuters

Consumer staples were the only S&P 500 sector in the green early Thursday, rising about 0.7%, according to Investopedia. Hershey surged about 8% after results and a bullish 2026 outlook, while Costco and Coca-Cola also gained.

In company-specific disclosures, an SEC filing showed Ma. Fatima Francisco, CEO of P&G’s Baby, Feminine & Family Care business, sold 8,000 shares on Feb. 4 at $158 per share. The filing also indicated the trade was under a Rule 10b5-1 plan — a pre-arranged trading plan used to reduce the risk of insider-trading accusations.

A separate SEC Form 144 filing showed P&G officer Gary A. Coombe proposed selling up to 72,186 shares tied to an exercise-and-sale of stock options, with an aggregate market value just over $11 million. Form 144 is a notice of a potential sale of restricted or control securities, not proof the shares were sold.

The last major fundamental reset for the stock came on Jan. 22, when P&G reported quarterly net sales of $22.21 billion, slightly below analysts’ estimates, while adjusted earnings per share of $1.88 topped expectations. “We need to get the U.S. growing,” CFO Andre Schulten said on the call. Reuters

In the company’s earnings release, CEO Shailesh Jejurikar said, “Our results in the second quarter keep us on track,” while keeping full-year ranges in place. P&G maintained its core EPS outlook of $6.83 to $7.09 and pegged tariff-related costs at about $400 million after tax for fiscal 2026. Procter & Gamble

Analysts have been split since the earnings print, but some have leaned more constructive. JPMorgan upgraded P&G to “overweight” on Jan. 23 and raised its price target to $165, saying the company was “poised to accelerate organic sales growth.” Investing.com

But the defensive bid can turn quickly. If the tech washout stabilizes, money can swing back into growth just as fast as it left — and staples can get hit simply for being the place investors hid.

Next on the macro calendar are key U.S. data points that can steer risk appetite, including the Employment Situation report for January due on Feb. 11 and the January CPI on Feb. 13, the BLS schedule shows. For P&G holders, the next near-term date is the quarterly dividend, payable on or after Feb. 17.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Molina Healthcare: Market Sentiment Misses the Mark
    July 19, 2026, 6:19 AM EDT. The market's reading of Molina Healthcare's valuation appears mistaken, opening a window for investors. An independent finance expert, experienced in macroeconomic analysis, technical patterns, and momentum-driven trading, makes the case that shares are currently undervalued. The analyst's method prioritises capital protection and a favourable risk-reward profile, blending Growth At A Reasonable Price (GARP) with momentum strategies for a balanced investment framework. The article highlights Molina Healthcare's prospects with actionable, data-backed observations in a turbulent market, encouraging investors to reassess the cautious outlook now prevailing.
NIO stock jumps after profit alert flags first quarterly operating profit — what investors watch next
Previous Story

NIO stock jumps after profit alert flags first quarterly operating profit — what investors watch next

Heating Oil Price Today: ULSD slips in early trade as Iran talks, tight distillates stay in focus
Next Story

Heating Oil Price Today: ULSD slips in early trade as Iran talks, tight distillates stay in focus

Go toTop